nCap Medical LLC announces it has accumulated anecdotal evidence

nCap Medical LLC announced it has accumulated anecdotal evidence that its non-invasive, Neurocuple(tm) technology has mitigated both acute and chronic pain without the need of opioids.

The Company’s teaming partner, the Sidra Academic and Research Hospital, will conduct random, double blind studies. The Academic Teaching Faculty WCMC supports the Institution: Qatar Ministry of Health and its other partner institutions at Education City, Qatar (Georgetown University, Carnegie Mellon University, Weill-Cornell Medicine in Qatar, college of the North Atlantic and HEC, Paris).

Dr. G. Russel Reiss, MD, Cardiothoracic Surgery,  formerly at the University of Utah, commented, “If the studies of the nCap nano-technology based material reveal efficaciousness, this could have one of the most significant impacts on the practice of medicine and effectively address the misuse and abuse of opioids.”

Dr. Joseph Shumway, MD,MPH FACOG, Senior Consultant, Hamad Medical Corporation; Senior Attending Physician, Weill Cornell Medical College Academic Faculty, Qatar, will manage the study, and attempt to better understand the mechanism of action of the nCap material together with Dr. Arthur Penn Ramirez a physicist at the University of California, Santa Clara.

Dr. Shumway is a small, minority owner of a membership interest in nCap.